Adams, David S.
The purpose of this project was to investigate whether induced pluripotent stem cells (iPSCs) can potentially replace the more controversial embryonic stem cells (ESCs) in therapies. A literature review was performed followed by interviews with key stakeholders in the stem cell field. Our findings indicate that several potential problems exist with iPSCs before they can be used in human therapies, including their slow expansion, the potential for cancer, and the potential for immune-rejection of the injected cells. We identified several best-practice procedures for overcoming each of these problems, but conclude that more studies should be performed directly comparing the effectiveness of iPSCs versus ESCs for specific therapies.
Worcester Polytechnic Institute
Interactive Qualifying Project
All authors have granted to WPI a nonexclusive royalty-free license to distribute copies of the work, subject to other agreements. Copyright is held by the author or authors, with all rights reserved, unless otherwise noted.
Biology and Biotechnology